jPK: Randomized Controlled Study of Plasmaknife Tonsillectomy Versus Monopolar Tonsillectomy

Sponsor
Children's Hospital of Michigan (Other)
Overall Status
Unknown status
CT.gov ID
NCT00466544
Collaborator
(none)
100
1

Study Details

Study Description

Brief Summary

Study objective is to provide prospective randomized controlled data on pediatric pain levels found in PlasmaKnife tonsillectomy and monopolar tonsillectomy.

Condition or Disease Intervention/Treatment Phase
  • Device: Plasmaknife
  • Device: Monopolar
Phase 4

Detailed Description

This is a prospective, randomized controlled study to compare the efficacy of the Gyrus ACMI PlasmaKnifeā„¢ electrosurgical device used with the Gyrus ACMI Workstation versus monopolar electrosurgical device (i.e. BovieĀ®) for tonsillectomy.

The primary outcome will study the potential for reduced post-operative pain when the PlasmaKnife is used for tonsillectomy compared to a monopolar device. Secondary outcomes such as return to normal diet and activity as well as a range of complications including primary and secondary bleeding will be included in the study.

The study will involve approximately 100 patients at Children's Hospital of Michigan that meet the criteria for tonsillectomy (with or without adenoidectomy) for infected tonsils or airway obstruction.

The study will be documented through the use of Case Report Forms.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Study Start Date :
May 1, 2007

Outcome Measures

Primary Outcome Measures

  1. pain []

Secondary Outcome Measures

  1. return to normal activity []

  2. return to normal diet []

  3. medication dose taken []

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 16 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Patient should be between the ages of 4 and 16 years old inclusive.

  • Patient should meet criteria for tonsillectomy.

  • Patient's guardian able and willing to complete patient diary and keep to the follow-up visit.

  • Guardian able to understand English (written and oral).

Exclusion Criteria:
  • Patient that has active medical implant(s) such as pacemaker, cochlear implant, etc.

  • Patient has abnormal blood coagulation, history of easy bruising, bleeding disorders or uses anti-coagulants.

  • Morbidly obese children (calculated BMI over 39)

  • Patient that has history of malignancy or acute peritonsillar abscess

  • Patient has Sickle Cell disease or is immunocompromised.

  • Patient is pregnant or lactating.

  • Active infection with fever greater than 101.5 degrees F.

  • History of heart disease, diabetes or hypertension (with systolic blood pressure > 160 mmHg).

  • Craniofacial anomaly.

  • Biopsy of tonsil needed to rule out neoplasm.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Detroit Children's Hospital Detroit Michigan United States 48201

Sponsors and Collaborators

  • Children's Hospital of Michigan

Investigators

  • Principal Investigator: David Madgy, Detroit Children's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00466544
Other Study ID Numbers:
  • 036706MP4F
First Posted:
Apr 27, 2007
Last Update Posted:
Apr 27, 2007
Last Verified:
Mar 1, 2007
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2007